Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Pfkfb4em1flox/Cya
Common Name:
Pfkfb4-flox
Product ID:
S-CKO-09889
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Pfkfb4-flox
Strain ID
CKOCMP-270198-Pfkfb4-B6J-VA
Gene Name
Pfkfb4
Product ID
S-CKO-09889
Gene Alias
C230090D14
Background
C57BL/6JCya
NCBI ID
270198
Modification
Conditional knockout
Chromosome
9
Phenotype
MGI:2687284
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Pfkfb4em1flox/Cya mice (Catalog S-CKO-09889) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000198140
NCBI RefSeq
NM_173019
Target Region
Exon 2~3
Size of Effective Region
~1.2 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Pfkfb4, or 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 4, is a key regulator of glycolysis, possessing both kinase and phosphatase functions. It is involved in the Warburg effect, which provides the metabolic basis for cancer cell proliferation and metastasis [1-10]. Genetic models, such as gene knockout (KO) mouse models, can be valuable for studying its functions.

In lung squamous cell carcinoma, THOC3 can form a complex with YBX1 to promote PFKFB4 transcription, with THOC3 responsible for exporting PFKFB4 mRNA to the cytoplasm and YBX1 ensuring its stability. Down-regulation of PFKFB4 suppressed the biological activities of the cancer cells [1].

In hepatocellular carcinoma (HCC), PFKFB4 expression was up-regulated, correlating positively with TP53 and TSC2 loss-of-function mutations. Nuclease technology-mediated PFKFB4 knockout significantly impaired in vivo HCC development, and its loss induced hypoxia-responsive genes in glycolysis and reactive oxygen species detoxification [2].

In glioma stem cells, PTBP1 lactylation enhanced RNA-binding capacity and facilitated PFKFB4 mRNA stabilization, increasing glycolysis and promoting glioma progression [3].

In endometriosis, PIM2 phosphorylated PFKFB4 at Thr140, promoting anaerobic glycolysis and cell proliferation [4].

In glioblastoma, PFKFB4 was essential for glioblastoma stem-like cell survival, regulating the ubiquitylation and proteasomal degradation of HIF-1α [5].

In melanoma, PFKFB4 interacted with ICMT, activating RAS/AKT-signaling-dependent cell migration [6].

In cervical cancer, PFKFB4 was abnormally increased, boosting the malignant progression of the cancer cells [7].

In breast cancer, PFKFB4 promoted angiogenesis via IL-6/STAT5A/P-STAT5 signaling [8].

In non-small cell lung cancer (NSCLC), PFKFB4 expression was enhanced, and high expression was associated with a worse prognosis, also being related to immune cell infiltration and immunological checkpoints [9].

In conclusion, Pfkfb4 plays a crucial role in glycolysis-related metabolic reprogramming, significantly influencing the development and progression of various cancers, including lung, liver, glioma, endometriosis-associated, glioblastoma, melanoma, cervical, breast, and NSCLC. Studies using KO models have been instrumental in revealing these functions in specific disease contexts, helping to understand the underlying mechanisms and potentially guiding new therapeutic strategies.

References:
1. Yu, Tao, Zhang, Qi, Yu, Shao-Kun, Wang, Qian, Lu, Kai-Hua. 2023. THOC3 interacts with YBX1 to promote lung squamous cell carcinoma progression through PFKFB4 mRNA modification. In Cell death & disease, 14, 475. doi:10.1038/s41419-023-06008-3. https://pubmed.ncbi.nlm.nih.gov/37500615/
2. Kam, Charles Shing, Ho, Daniel Wai-Hung, Ming, Vanessa Sheung-In, Chan, Lo-Kong, Ng, Irene Oi-Lin. 2023. PFKFB4 Drives the Oncogenicity in TP53-Mutated Hepatocellular Carcinoma in a Phosphatase-Dependent Manner. In Cellular and molecular gastroenterology and hepatology, 15, 1325-1350. doi:10.1016/j.jcmgh.2023.02.004. https://pubmed.ncbi.nlm.nih.gov/36806581/
3. Zhou, Zijian, Yin, Xianyong, Sun, Hao, Wang, Shan, Xin, Tao. . PTBP1 Lactylation Promotes Glioma Stem Cell Maintenance through PFKFB4-Driven Glycolysis. In Cancer research, 85, 739-757. doi:10.1158/0008-5472.CAN-24-1412. https://pubmed.ncbi.nlm.nih.gov/39570804/
4. Lu, Chao, Qiao, Pengyun, Fu, Ruihai, Ren, Chune, Yu, Zhenhai. 2022. Phosphorylation of PFKFB4 by PIM2 promotes anaerobic glycolysis and cell proliferation in endometriosis. In Cell death & disease, 13, 790. doi:10.1038/s41419-022-05241-6. https://pubmed.ncbi.nlm.nih.gov/36109523/
5. Phillips, Emma, Balss, Jörg, Bethke, Frederic, Fendt, Sarah-Maria, Goidts, Violaine. 2022. PFKFB4 interacts with FBXO28 to promote HIF-1α signaling in glioblastoma. In Oncogenesis, 11, 57. doi:10.1038/s41389-022-00433-3. https://pubmed.ncbi.nlm.nih.gov/36115843/
6. Sittewelle, Méghane, Kappès, Vincent, Zhou, Chenxi, Lécuyer, Déborah, Monsoro-Burq, Anne H. 2022. PFKFB4 interacts with ICMT and activates RAS/AKT signaling-dependent cell migration in melanoma. In Life science alliance, 5, . doi:10.26508/lsa.202201377. https://pubmed.ncbi.nlm.nih.gov/35914811/
7. Sun, Junxia, Jin, Ruiying. 2022. PFKFB4 modulated by miR-195-5p can boost the malignant progression of cervical cancer cells. In Bioorganic & medicinal chemistry letters, 73, 128916. doi:10.1016/j.bmcl.2022.128916. https://pubmed.ncbi.nlm.nih.gov/35926796/
8. Li, Dan, Tang, Jiaping, Gao, Ruifang, Nie, Yongwei, Luo, Na. 2022. PFKFB4 promotes angiogenesis via IL-6/STAT5A/P-STAT5 signaling in breast cancer. In Journal of Cancer, 13, 212-224. doi:10.7150/jca.66773. https://pubmed.ncbi.nlm.nih.gov/34976184/
9. Zhou, Yong, Fan, Yongfei, Qiu, Binzhe, Yuan, Kai, Tong, Jichun. 2022. Effect of PFKFB4 on the Prognosis and Immune Regulation of NSCLC and Its Mechanism. In International journal of general medicine, 15, 6341-6353. doi:10.2147/IJGM.S369126. https://pubmed.ncbi.nlm.nih.gov/35942289/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest